A comparison of CA125, HE4, risk ovarian malignancy algorithm (ROMA), and risk malignancy index (RMI) for the classification of ovarian masses

OBJECTIVE: Differentiation between benign and malignant ovarian neoplasms is essential for creating a system for patient referrals. Therefore, the contributions of the tumor markers CA125 and human epididymis protein 4 (HE4) as well as the risk ovarian malignancy algorithm (ROMA) and risk malignancy...

Descripción completa

Detalles Bibliográficos
Autores principales: Anton, Cristina, Carvalho, Filomena Marino, Oliveira, Elci Isabel, ArantesRosaMaciel, Gustavo, Baracat, Edmund Chada, Carvalho, Jesus Paula
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo 2012
Materias:
Clinical Science
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3351260/
https://www.ncbi.nlm.nih.gov/pubmed/22666786
http://dx.doi.org/10.6061/clinics/2012(05)06

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3351260/
https://www.ncbi.nlm.nih.gov/pubmed/22666786
http://dx.doi.org/10.6061/clinics/2012(05)06

Ejemplares similares